Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2007
DOI: 10.1128/jvi.01601-06
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Filovirus Replication by the Zinc Finger Antiviral Protein

Abstract: The zinc finger antiviral protein (ZAP) was recently shown to inhibit Moloney murine leukemia virus and Sindbis virus replication. We tested whether ZAP also acts against Ebola virus (EBOV) and Marburg virus (MARV). Antiviral effects were observed after infection of cells expressing the N-terminal part of ZAP fused to the product of the zeocin resistance gene (NZAP-Zeo) as well as after infection of cells inducibly expressing full-length ZAP. EBOV was inhibited by up to 4 log units, whereas MARV was inhibited … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

3
170
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 188 publications
(179 citation statements)
references
References 24 publications
(36 reference statements)
3
170
0
Order By: Relevance
“…Since filoviruses encode their own replication/transcription machinery, the components involved in replication/transcription; cis-acting elements on the genomes and VPs mediating replication/transcription, are ideal targets for antiviral strategies. Indeed, initial approaches to use viral genes and proteins involved in replication/transcription as targets for antiviral compounds were quite promising [59,63,[67][68][69][70]. Thus, a deeper understanding of the way in which filoviruses replicate and transcribe their genomes will lead to potential benefits in controlling filovirus infections.…”
Section: Future Perspectivementioning
confidence: 99%
“…Since filoviruses encode their own replication/transcription machinery, the components involved in replication/transcription; cis-acting elements on the genomes and VPs mediating replication/transcription, are ideal targets for antiviral strategies. Indeed, initial approaches to use viral genes and proteins involved in replication/transcription as targets for antiviral compounds were quite promising [59,63,[67][68][69][70]. Thus, a deeper understanding of the way in which filoviruses replicate and transcribe their genomes will lead to potential benefits in controlling filovirus infections.…”
Section: Future Perspectivementioning
confidence: 99%
“…In addition to MLV, overexpression of ZAP also inhibits the replication of Ebola virus and Marburg virus (2), and several members of the Alphavirus genus, including Sindbis virus (SINV) (3). IFN treatment or SINV infection of murine bone marrow-derived dendritic cells significantly up-regulates the expression level of ZAP (4), suggesting that ZAP also may function as an antiviral effector in vivo.…”
mentioning
confidence: 99%
“…In addition to MMLV, ZAP inhibits the replication of HIV-1 (2), Ebola virus and Marburg virus (3), and certain alphaviruses such as Sindbis virus, Ross River virus, and Semliki Forest virus (4,5). ZAP is not a universal antiviral factor because it does not inhibit the replication of viruses such as poliovirus and yellow fever virus (5).…”
mentioning
confidence: 99%
“…The zinc-finger antiviral protein (ZAP) 3 was originally isolated as a host factor that inhibits the replication of Moloney murine leukemia virus (MMLV) (1). In addition to MMLV, ZAP inhibits the replication of HIV-1 (2), Ebola virus and Marburg virus (3), and certain alphaviruses such as Sindbis virus, Ross River virus, and Semliki Forest virus (4,5).…”
mentioning
confidence: 99%